Ethyl Acetate

Ethyl Acetate

SCHEMBL5413296

CCOC(C)=O.CCOC(C)=O.ClC(Cl)Cl.ClC(Cl)Cl.ClC(Cl)Cl.ClC(Cl)Cl.ClC(Cl)Cl

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.78
LMNA P02545 1/20 0.78
HSD17B10 Q99714 1/20 0.78
TSHR P16473 1/20 0.48
GAA P10253 2/20 0.43
ALOX15 P16050 1/20 0.43
MGAM O43451 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
SOAT1 P35610 1/20 0.43
TRPA1 O75762 1/20 0.40
GLO1 Q04760 1/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
CHRM5 P08912 2/20 0.37
CHRM1 P11229 2/20 0.37
CHRM3 P20309 2/20 0.37
PGR P06401 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL1334416 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL10364372 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL11181789 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL6473397 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL5861946 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1715654 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL6268192 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1392317 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL8740178 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL561021 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7199147-B2 Rho kinase inhibitors DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-04-03 US disclosed
US-20040138286-A1 Rho kinase inhibitors DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2004-07-15 US disclosed
EP-1403255-A1 Rho KINASE INHIBITORS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-03-31 EP disclosed
US-5817816-A SIDE EFFECT REDUCTION MEIJI SEIKA KAISHA, LTD. (JP) 1998-10-06 US disclosed
EP-0820995-A1 Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same Meiji Seika Kaisha, Ltd. (JP) 1998-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138286-A1 Rho kinase inhibitors ROCK1, ROCK2, ARHGDIA ALDH1A1 3541/4885LMNA 2226/4885HSD17B10 3004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.